Get access
Clinical & Experimental Allergy

Socio-economic status, geographic remoteness and childhood food allergy and anaphylaxis in Australia

Authors

  • R. J. Mullins,

    1. Suite 1, John James Medical Centre, Deakin, ACT, Australia
    2. Medical School, Australian National University, Canberra, ACT, Australia
    3. Clinical Immunology, Faculty of Health, University of Canberra, Canberra ACT, Australia
    Search for more papers by this author
  • S. Clark,

    1. Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Search for more papers by this author
  • C. A. Camargo Jr.

    1. Department of Emergency Medicine
    2. Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Search for more papers by this author

Correspondence:
R. J. Mullins, Clinical Immunology and Allergy, Suite 1, John James Medical Centre, 175 Strickland Crescent, Deakin, ACT 2600, Australia. E-mail: rmullins@allergycapital.com.au

Summary

Background The risk factors for food allergy (FA) and anaphylaxis remain uncertain.

Objective We examined the association between socio-economic status (SES), geographic remoteness and childhood FA and anaphylaxis in Australia.

Methods Sales of infant hypoallergenic formulae (IHF; 2008–2009) and EpiPens (2006–2007) in children aged 0–4 years and hospital anaphylaxis admission rates (2002–2006) in age groups 0–4, 5–14, 15–24, 25–64 and 65+ years were used as proxy markers of FA and anaphylaxis in Australia. Government and commercially derived data were analysed by SES and geographic remoteness (very remote, remote, outer regional, inner regional and major cities).

Results Annual IHF sales rates were higher in those with the greatest compared with the least socio-economic advantage (47 830 vs. 21 384 tins/100 000 population; P<0.001). EpiPen sales trends were also higher in those with the greatest socio-economic advantage in all age groups, most marked in those aged 0–4 (1713 vs. 669/100 000; P=0.002) and 5–14 years (1628 vs. 600/100 000; P=0.001). Formula sales rates were higher in major cities than remote/very remote regions (37 421 vs. 6704/100 000; P<0.001) with similar EpiPen sales trends, particularly in ages 0–4 (1166 vs. 601/100 000; P=0.045) and 5–14 years (1099 vs. 588/100 000; P<0.001). Socio-economic advantage and geographic remoteness remained statistically significant in multivariable analysis of prescription rates (P<0.01) and were unchanged by adjustment for health services access. While anaphylaxis admission rates were higher in those with the greatest compared with the least socio-economic advantage in children aged 0–4 years (129 vs. 92/100 000 population/year; P=0.03), the opposite was observed in older age groups (e.g. aged 25–64 years: 43 vs. 76, P=0.01). There was no association between geographic remoteness and anaphylaxis admissions.

Conclusion Socio-economic advantage and residence in major cities may be risk factors for developing childhood FA and anaphylaxis. Further study will determine the extent to which economic factors and location of residence also influence access to health services.

Cite this as: R. J. Mullins, S. Clark and C. A. Camargo Jr., Clinical & Experimental Allergy, 2010 (40) 1523–1532.

Get access to the full text of this article

Ancillary